Open Access · CC BY 3.0
Vaccines against Alzheimer’s disease: Clinical trial evidence, safety and endpoint design
Pharmacotherapy in Psychiatry and Neurology · 2026
DOI: 10.17219/fpn/242038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacotherapy in Psychiatry and Neurology, 2026. Verfasst von Wiktor Tomasz Gawełczyk und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gawełczyk, W. T., Chmiel, J., & Leszek, J. (2026). Vaccines against Alzheimer’s disease: Clinical trial evidence, safety and endpoint design. Pharmacotherapy in Psychiatry and Neurology. https://doi.org/10.17219/fpn/242038
Vancouver
Gawełczyk WT, Chmiel J, Leszek J. Vaccines against Alzheimer’s disease: Clinical trial evidence, safety and endpoint design. Pharmacotherapy in Psychiatry and Neurology. 2026. doi:10.17219/fpn/242038
BibTeX
@article{Gaweczyk2026,
author = {Gawełczyk, Wiktor Tomasz and Chmiel, James and Leszek, Jerzy},
title = {Vaccines against Alzheimer’s disease: Clinical trial evidence, safety and endpoint design},
journal = {Pharmacotherapy in Psychiatry and Neurology},
year = {2026},
doi = {10.17219/fpn/242038}
}
EUVIMED